AbbVie
AbbVie's revenue from Humira accounted for about 60.0% of its revenue in 1Q16. If such an important cash cow is in danger, Think it wise to sell the shares.
Normally I do not to sell shares. There are exceptions when the fundamentals have changed. This is the case with AbbVie. Can AbbVie be a buy in the future?
Have you copied pasted your question from this
seeking alpha article?
I'm more interested if it's a sell or a short right now, what do you think?